ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
ProShares Ether ETF

ProShares Ether ETF (EETH)

51,93
1,48
(2,94%)
Geschlossen 15 Februar 10:00PM
51,15
-0,78
( -1,50% )
Vor Marktöffnung: 2:02PM

Calls

StrikeGebotFragenLetzter PreisMittelpreisÄnderungÄnderung %VolumenOPEN-INTLetzte Trade
41,000,000,000,000,000,000,00 %00-
42,000,000,000,000,000,000,00 %00-
43,007,8010,000,008,900,000,00 %00-
44,007,109,000,008,050,000,00 %00-
45,000,000,000,000,000,000,00 %00-
46,000,000,000,000,000,000,00 %00-
47,000,000,000,000,000,000,00 %00-
48,000,000,000,000,000,000,00 %00-
49,002,754,302,983,5250,000,00 %02-
50,002,053,302,902,6750,000,00 %04-
51,001,452,751,852,10-0,01-0,54 %1514.2.2025
52,001,152,002,101,575-0,41-16,33 %4314.2.2025
53,001,201,201,201,200,000,00 %04-
54,001,001,001,001,000,000,00 %04-
55,000,201,150,660,6750,1120,00 %23614.2.2025
56,001,371,371,371,370,000,00 %03-
57,000,050,750,450,400,000,00 %03-
58,000,940,750,940,8450,000,00 %010-
59,000,900,650,900,7750,000,00 %04-
60,000,150,700,150,4250,000,00 %08-

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Puts

StrikeGebotFragenLetzter PreisMittelpreisÄnderungÄnderung %VolumenOPEN-INTLetzte Trade
41,000,001,450,000,000,000,00 %00-
42,000,001,500,000,000,000,00 %00-
43,000,001,600,000,000,000,00 %00-
44,000,000,600,000,000,000,00 %00-
45,002,012,012,012,010,000,00 %017-
46,000,050,850,000,450,000,00 %00-
47,000,150,750,000,450,000,00 %00-
48,000,100,800,490,45-0,51-51,00 %1514.2.2025
49,000,250,951,500,600,000,00 %01-
50,000,840,840,840,840,000,00 %017-
51,001,141,141,141,140,000,00 %03-
52,001,501,501,501,500,000,00 %05-
53,000,000,000,000,000,000,00 %00-
54,002,103,603,702,850,000,00 %04-
55,002,502,502,502,500,000,00 %02-
56,004,405,306,404,850,000,00 %010-
57,006,596,596,596,590,000,00 %01-
58,002,502,502,502,500,000,00 %05-
59,006,408,408,607,400,000,00 %01-
60,007,309,3010,108,300,000,00 %027-
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SLDBSolid Biosciences Inc
US$ 7,02
(74,19%)
17,06M
EFOIEnergy Focus Inc
US$ 2,15
(66,67%)
15,92M
INTGIntergroup Corporation
US$ 22,80
(61,13%)
6
EDRYEuroDry Ltd
US$ 16,69
(58,95%)
8
FGMCFG Merger II Corporation
US$ 14,85
(54,45%)
11
RSLSReShape Lifesciences Inc
US$ 0,99
(-57,51%)
1,29M
INNVInnovAge Holding Corporation
US$ 1,81
(-46,61%)
1
KTCCKeyTronic Corporation
US$ 2,01
(-36,79%)
1
DAREDare Bioscience Inc
US$ 2,01
(-33,88%)
3
BPTHBio Path Holdings Inc
US$ 0,4199
(-33,69%)
595,09k
ADTXAditxt Inc
US$ 0,0826
(18,00%)
160,77M
GLYCGlycoMimetics Inc
US$ 0,3679
(26,86%)
26,82M
HCTIHealthcare Triangle Inc
US$ 0,7388
(54,27%)
21,67M
DGLYDigital Ally Inc
US$ 0,0812
(5,87%)
20,43M
SLDBSolid Biosciences Inc
US$ 7,02
(74,19%)
17,06M
i_like_bb_stock i_like_bb_stock 3 Minuten vor
ADIA news Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products https://www.otcmarkets.com/stock/ADIA/news/Adia-Med-Partners-with-Premier-FDA-Approved-Lab-for-High-Quality-Umbilical-Cord-Stem-Cell-and-Exosome-Products?id=467906
ADIA
i_like_bb_stock i_like_bb_stock 3 Minuten vor
nice
Juntao Juntao 3 Minuten vor
$ADIA
ADIA
i_like_bb_stock i_like_bb_stock 3 Minuten vor
news Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products https://www.otcmarkets.com/stock/ADIA/news/Adia-Med-Partners-with-Premier-FDA-Approved-Lab-for-High-Quality-Umbilical-Cord-Stem-Cell-and-Exosome-Products?id=467906
ADIA
i_like_bb_stock i_like_bb_stock 4 Minuten vor
ADIA news Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products https://www.otcmarkets.com/stock/ADIA/news/Adia-Med-Partners-with-Premier-FDA-Approved-Lab-for-High-Quality-Umbilical-Cord-Stem-Cell-and-Exosome-Products?id=467906
ADIA
IhidfromtheX IhidfromtheX 4 Minuten vor
Ok...Talk of the FDA slowing down etc...No problem here... https://finance.yahoo.com/news/chimerix-announces-fda-acceptance-priority-120000372.html
AVXL
Sideem Sideem 4 Minuten vor
Good to see the pre-green. Will the green stay?
BB
georgie18 georgie18 4 Minuten vor
AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...
AVGR
georgie18 georgie18 5 Minuten vor
AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...
AVGR
Here Today Here Today 5 Minuten vor
Huge Believer and buyer of shares of more than 9.99% of all Outstanding Shares

https://www.sec.gov/Archives/edgar/data/1829635/000095017025021455/xslSCHEDULE_13G_X01/primar
RNAZ
georgie18 georgie18 5 Minuten vor
AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...
AVGR
Crawfors Crawfors 5 Minuten vor
46.5% margins are pretty dang impressive. Can't be upset about that.

$EDXC
EDXC
georgie18 georgie18 5 Minuten vor
AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...
AVGR
TheFinalCD TheFinalCD 5 Minuten vor
https://x.com/NuntioBot/status/1891835713668161922
PRPH
Crawfors Crawfors 5 Minuten vor
• Revenue increased 164% year-over-year, reaching $632K in Q4 2024, demonstrating growing demand for our products.

• Our gross margin improved to 46.5%, indicating enhanced financial efficiency.

$EDXC
EDXC
Crawfors Crawfors 6 Minuten vor
Acknowledging the Challenges
It’s no secret that our financial position has been strained, with limited working capital and a heavy reliance on convertible financing in the past. We’ve experienced dilution, debt pressure, and cash flow constraints, all of which have made it difficult to opera
EDXC
Torez Torez 6 Minuten vor
Lots of comedians in here. Short bus party not a yaht party for you all
SHIBUSD
Crawfors Crawfors 6 Minuten vor
https://www.newmediawire.com/news/endexx-corporation-announces-filing-of-q4-2024-financials-removal-of-yield-sign-and-ceo-update-on-growth-strategy-7079432?fbclid=IwY2xjawIhZiJleHRuA2FlbQIxMAABHbyr1bnNTeqMN7dIxtbLtKWPJT_Z-BarsdskOUFhhbk4Yv8wmDhd56UjXg_aem_MXr--hJ2dCo1HspBvETtkA
EDXC
newmedman newmedman 7 Minuten vor
Bombs are going to fly. If you thought trump was a dumbfuck just wait for what's coming.
RobotDroid RobotDroid 7 Minuten vor
A no name reasearch group spews fiction for the paid pumpers. Wow, not impressive at all. Hopium rules, reality falls!
NWBO
AyaStocks AyaStocks 7 Minuten vor
GM $ADIA players! Watching for a move back up to higher levels today. This is way undervalued here below a dime.
ADIA
Crawfors Crawfors 8 Minuten vor
oh okay cool.
EDXC
Here Today Here Today 8 Minuten vor
Watch Out FDA!!!! There is a new Sheriff in town and all your CROOKED DEALS with those Big Pharma's of the world trying to STOP and Destroy new Treatments and or cures before they can begin is coming to an end in my opinion!!!!
ANVS
fredscott36 fredscott36 8 Minuten vor
25/marty to venable.








...
georgie18 georgie18 9 Minuten vor
SEPN...$13.70...🥳...T3 Halt...

georgie18

Member Level
Re: georgie18 post# 674144

Friday, February 14, 2025 3:31:11 PM

Post#
674545
of 674615
SEPN...$13.03...🥳...Slowly creeping up...

Kürzlich von Ihnen besucht

Delayed Upgrade Clock